Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

about

Bone health in subjects with type 1 diabetes for more than 50 years.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Skeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes Mellitus

P2860

Q38943012-93CA4B99-D37C-4358-8BD7-5B228D451AFD Q39137277-2DEB8BB9-5477-4DF8-96BB-1CABC00FA4AB Q58766909-431550F7-9A7D-4971-A29D-74C1E8AEFDA2

P2860

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Item

http://www.wikidata.org/entity/Q38972521

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

@en

type

Item

label

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

@en

prefLabel

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

@en

P1476

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

@en

P2093

Ernesto Maddaloni

http://www.w3.org/2001/XMLSchema#string

Hillary A Keenan

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition

Management of endocrine disease: Diabetes and osteoporosis: cause for concern?

Alteration of trabecular bone under chronic beta2 agonists treatment

Bone mineral acquisition in adolescents with type 1 diabetes.

Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.

Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers.

Role of vascular endothelial growth factor in diabetic vascular complications.

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover.

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Beta-1 adrenergic agonist treatment mitigates negative changes in cancellous bone microarchitecture and inhibits osteocyte apoptosis during disuse.

P2888

s11914-016-0338-8

P304

351-358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-016-0338-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012932540

http://www.w3.org/2001/XMLSchema#string

P698

27704394

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5106327

http://www.w3.org/2001/XMLSchema#string

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

about

P2860

P2860

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932